research use only

DMF(N,N-Dimethylformamide)

Cat.No.S6192

DMF(N,N-Dimethylformamide) is a polar organic solvent with a wide range of industrial applications.This product is a hazardous chemical (acute toxicity/flammable/skin corrosive). Please use it while wearing a protective face mask, gloves, and clothing.
Jump to

Quality Control

99

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 73.09 Formula

C3H7NO

Storage (From the date of receipt) 2 years 4°C liquid
CAS No. 68-12-2 --
Synonyms N/A SMILES CN(C)C=O

Read more about storage stability stock solution CAS number SMILES

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-03-19)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07483632 NOT_YET_RECRUITING
Relapsing Forms of Multiple Sclerosis
Biogen
2026-11-16 PHASE3
NCT05463133 RECRUITING
Chronic Granulomatous Disease
National Institute of Allergy and Infectious Diseases (NIAID)
2022-07-08 PHASE1; PHASE2
NCT07330336 NOT_YET_RECRUITING
Neurodevelopmental Disorders
University Hospital, Bordeaux
2026-04
NCT07629817 RECRUITING
Esophageal Squamous Cell Carcinoma
Henan Cancer Hospital
2026-06-16 PHASE3
NCT07704957 NOT_YET_RECRUITING
Chlamydia Females; Gonorrhea Female; Syphilis Female; Adherence; Prophylaxis; Prevention
Tulane University
2027-01-01 PHASE4
NCT01042379 RECRUITING
Breast Neoplasms; Breast Cancer; Breast Tumors; Angiosarcoma; TNBC - Triple-Negative Breast Cancer; HER2-positive Breast Cancer; HER2-negative Breast Cancer; Hormone Receptor Positive Tumor; Hormone Receptor Negative Tumor; Early-stage Breast Cancer; Locally Advanced Breast Cancer
QuantumLeap Healthcare Collaborative
2010-03-01 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.